How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Tube and Vial Capper-Decapper Market
- By Equipment Type: Manual Tube and Vial Capper-Decapper, Semi-Automatic Tube and Vial Capper-Decapper, Fully Automatic Tube and Vial Capper-Decapper
- By Cap Type Compatibility: Screw Caps, Snap Caps, Crimp Caps, Flip-Off Caps
- By Application: Pharmaceutical, Biotechnology, Clinical Diagnostics, Food and Beverage, Chemical
- By Material Compatibility: Glass Tubes and Vials, Plastic Tubes and Vials
- By Operation Mode: Single-Station Capping, Multi-Station Capping
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Manual Tube and Vial Capper-Decapper leads By Equipment Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Tube and Vial Capper-Decapper Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Equipment Type 3
Cap Type Compatibility 4
Application 5
Material Compatibility 2
Operation Mode 2
Companies profiled
Thermo Fisher Scientific
Sartorius AG
Merck KGaA (MilliporeSigma)
GE Healthcare Life Sciences
Tecan Group Ltd.
Hamilton Company
Agilent Technologies
PerkinElmer Inc.
Eppendorf AG
Bio-Rad Laboratories
Waters Corporation
Danaher Corporation
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →GE Healthcare Life Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Tecan Group Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Hamilton Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Agilent Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →PerkinElmer Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Eppendorf AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Bio-Rad Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Waters Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Danaher Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Beckman Coulter
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Fisher Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,872M by 2033 · 9.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Manual Tube and Vial Capper-Decapper54.7
- Semi-Automatic Tube and Vial Capper-Decapper28.1
- Fully Automatic Tube and Vial Capper-Decapper17.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$455.4M → $851.1M · 8.1%
Europe$317.4M → $717.1M · 10.7%
Asia Pacific$289.8M → $568.7M · 8.8%
Latin America$179.4M → $388.0M · 10.1%
Middle East and Africa$138.0M → $283.2M · 9.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.542026
9.562027
9.562028
9.572029
9.592030
9.602031
9.622032
9.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific13.1
- Sartorius AG26.7
- Merck KGaA (MilliporeSigma)8.8
- GE Healthcare Life Sciences5.8
- Tecan Group Ltd.12.3
- Hamilton Company5.2
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Equipment Type23.2%
Cap Type Compatibility25.2%
Application13.0%
Material Compatibility22.2%
Operation Mode16.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.3
- Europe25.5
- Asia Pacific20.3
- Latin America13.8
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 77 | 75 | 89 | 98 | 85 | 84 | 85 |
| Sartorius AG | 84 | 85 | 75 | 92 | 91 | 81 | 85 |
| Merck KGaA (MilliporeSigma) | 76 | 68 | 65 | 78 | 72 | 69 | 71 |
| GE Healthcare Life Sciences | 58 | 57 | 60 | 78 | 68 | 57 | 63 |
| Tecan Group Ltd. | 64 | 66 | 63 | 54 | 74 | 54 | 63 |
| Hamilton Company | 48 | 65 | 57 | 61 | 53 | 50 | 56 |
| Agilent Technologies | 54 | 52 | 41 | 40 | 62 | 59 | 51 |
| PerkinElmer Inc. | 46 | 35 | 58 | 44 | 56 | 45 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Sartorius AG
- Merck KGaA (MilliporeSigma)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Sartorius AG | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Merck KGaA (MilliporeSigma) | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| GE Healthcare Life Sciences | ◐ | ◐ | ◐ | ✓ | ◐ | − |
| Tecan Group Ltd. | ◐ | ◐ | − | − | ◐ | − |
| Hamilton Company | − | − | − | − | ◐ | ◐ |
| Agilent Technologies | − | − | − | ◐ | ◐ | − |
| PerkinElmer Inc. | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific85
2Sartorius AG85
3Merck KGaA (MilliporeSigma)71
4GE Healthcare Life Sciences63
5Tecan Group Ltd.63
6Hamilton Company56
7Agilent Technologies51
8PerkinElmer Inc.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificSartorius AG
Challenger1
Strong scale, closing on the leaders.
Merck KGaA (MilliporeSigma)
Contender2
Focused players with pockets of strength.
GE Healthcare Life SciencesTecan Group Ltd.
Niche3
Specialists in a single segment or region.
Hamilton CompanyAgilent TechnologiesPerkinElmer Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Equipment Type in North America, then scale across Tube and Vial Capper-Decapper Market — a $735M beachhead inside a $11.6B market.
Beachhead (SOM)$735Mobtainable near-term
Serviceable (SAM)$4.05Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Manual Tube and Vial Capper-Decapper
Best fit — highest urgency & budget in Equipment Type.
Economic buyer78 fit
Semi-Automatic Tube and Vial Capper-Decapper
Strong fit — clear ROI and a fast path to value.
End user65 fit
Fully Automatic Tube and Vial Capper-Decapper
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Equipment Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Cap Type Compatibility & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Equipment Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tube and Vial Capper-Decapper Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified23%
Evaluation14%
Closed-won8%
$10.8KCAC
$46KLTV
4.3:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tube and Vial Capper-Decapper Market is a high-growth opportunity — $5.15B by 2033, compounding at 11.5%.
TAM · 2025$2.15Btoday
TAM · 2033$5.15Bforecast
CAGR11.5%2027–2033
Cumulative$31.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.15BTotal addressable market
SAM$1.91BServiceable available market
SOM$380MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Equipment Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Equipment Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.15BLarge & growingTAM by 2033 at 11.5% CAGR
$1.91BServiceable nowreachable with today’s model
$380MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.02BBear7.5% CAGR
$5.15BBase11.5% CAGR
$6.60BBull15.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Cap Type Compatibility optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tube and Vial Capper-Decapper Market — a $9.79B market by 2033. Plan: grow share from 8.5% to 16.7%.
Market size · 2033$9.79Btotal addressable
Market CAGR7.3%2027–2033
Target share16.7%from 8.5% today
Revenue ambition$1.63Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 16.7% | On track |
| Revenue | $762M | $1.63B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 36.7% | 39.2% | At risk |
| Customer retention | 85.1% | 92.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Equipment Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Cap Type Compatibility capability
A defensible second engine — invest in Cap Type Compatibility to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Equipment Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Cap Type Compatibility
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $174M capacity & capability investment
- Greenlight bolt-on M&A in Cap Type Compatibility
- Authorise North America expansion plan
- Fund R&D program for Equipment Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tube and Vial Capper-Decapper Market conversation — a $6.74B market you can size, segment and defend in minutes.
Market size · 2033$6.74Btotal opportunity
Growth8.2%CAGR to 2033
Addressable buyers1,600+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Equipment Type
Goal Grow share in Equipment Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 3 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Thermo Fisher ScientificSartorius AGMerck KGaA (MilliporeSigma)GE Healthcare Life SciencesTecan Group Ltd.Hamilton CompanyAgilent TechnologiesPerkinElmer Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tube and Vial Capper-Decapper Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tube and Vial Capper-Decapper Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Tube and Stent Cutting Laser Systems Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportTube and Cryo Vial Freezing Container Market
Market size, share, segmentation and regional forecast.
$461M market · 2025 base year
View reportTUBB2B Antibody Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportTubatoxin Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportTubal Rings and Clips Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTubal Ligation Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportT-type Freeze Dryers Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportTTL Medical Loupes Market
Market size, share, segmentation and regional forecast.
$850M market · 2025 base year
View reportTTL Dental Surgical Loupes Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportTSLP Monoclonal Antibody Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportT-shaped Intrauterine Device Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTryptose Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.